Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RØNNINGEN BIO AS
AS
Active
Org 927092417
Djupdalsvegen 140, 7380 Ålen
Production of electricity from renewable sources · NACE 3512
Est. 2021
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2M
+7% vs 2023
EBITDA margin
80.7%
+201% vs 2023
Equity ratio
14.0%
Financial strength
Net profit 2024
NOK 749K
+3774% vs 2023
EBITDA — year on year
NOK millions
3M
2M
1M
1M
0M
0M
2021
1M
+100%
2022
1M
0%
2023
2M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 2M
+7%
EBITDA
NOK 1,6M
+201%
Net profit
NOK 749K
+3774%
Total assets
NOK 6,2M
+29%
Equity
NOK 876K
+589%
Employees
0
—
Company information
Legal name
RØNNINGEN BIO AS
Org number
927092417
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
10. mai 2021
Share capital
NOK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Produksjon og salg av bioenergi og annen virksomhet som naturlig hører inn under dette herunder investering i andre selskap.
Contact
Address
Djupdalsvegen 140, 7380 Ålen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Production of electricity from renewable sources
Companies in Holtålen
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
0M
2021
2M
2022
2M
2023
2M
2024
EBITDA
NOK millions
0M
1M
1M
2M
2M
0M
2021
1M
2022
1M
2023
2M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
78
1 578
1 849
1 970
Staff expenses
−0
−0
−0
−0
EBITDA
−30
894
529
1 589
Depreciation & amort.
−37
−271
−306
−310
EBIT
−67
623
222
1 280
Net financials
−87
−334
−248
−320
Profit before tax
−154
289
−26
960
Tax
−36
64
−6
211
Net profit
−118
225
−20
749
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
6 758
4 940
4 854
6 245
Equity
−78
148
127
876
Long-term debt
0
4 532
4 315
4 916
Short-term debt
6 836
261
412
453
Total debt
6 836
4 793
4 727
5 369
Financial ratios
5-year trend
EBITDA margin
80.7%
This company
15.8%
Market median
+411% vs market
2021
2024
Equity ratio
14.0%
This company
38.2%
Market median
-63% vs market
2021
2024
Return on equity
85.5%
This company
18.4%
Market median
+365% vs market
2021
2024
Net profit margin
38.0%
This company
8.1%
Market median
+369% vs market
2021
2024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
2021
2024
Debt / equity
6.13×
This company
0.62×
Market median
-889% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-04-21 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Per Langeng
Individual
20%
20%
2022
Hans Inge Jamtvoll Aasen
Individual
20%
20%
2022
Roar Aasen
Individual
20%
20%
2022
Per Bjarne Aftret Bergan
Individual
20%
20%
2022
Åge Bergan
Individual
20%
20%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of RØNNINGEN BIO AS also hold positions in
0
other companies.
Person
Role here
Other companies